SHI Hui, FAN Jian, WANG Wei, WANG Kaijian, NI Xiaodong, FAN Chunsun. Analysis of prognostic factors and competing risks in 14, 805 cases with tonsil squamous cell carcinoma from the SEER database[J]. Journal of Clinical Medicine in Practice, 2024, 28(23): 42-46, 51. DOI: 10.7619/jcmp.20244248
Citation: SHI Hui, FAN Jian, WANG Wei, WANG Kaijian, NI Xiaodong, FAN Chunsun. Analysis of prognostic factors and competing risks in 14, 805 cases with tonsil squamous cell carcinoma from the SEER database[J]. Journal of Clinical Medicine in Practice, 2024, 28(23): 42-46, 51. DOI: 10.7619/jcmp.20244248

Analysis of prognostic factors and competing risks in 14, 805 cases with tonsil squamous cell carcinoma from the SEER database

More Information
  • Received Date: September 13, 2024
  • Revised Date: October 27, 2024
  • Objective 

    To evaluate factors associated with prognosis of tonsil squamous cell carcinoma (TSCC) patients and analyze the competing risks of death in TSCC patients.

    Methods 

    Data tonsil malignant tumors cases diagnosed between 1975 and 2020 were obtained from the SEER database, and records confirmed as squamous cell carcinoma were selected. A Cox proportional hazards regression model was used to investigate the relationships of gender, race, age, marital status, year of diagnosis, lesion location, pathological evidence, treatment regimen with overall survival rate as well as cause-specific mortality outcomes. The competing risks of cause-specific death outcomes among TSCC patients with different clinical characteristics were assessed.

    Results 

    This study included 14, 805 TSCC patients, including 11, 650 males, accounting for 78.69%. 93.99% of TSCC cases were diagnosed after the age of 45, with the highest incidence occurring in 45 to 64 age group. Radiotherapy was the most commonly used treatment modality (81.78%), compared to surgery (49.47%) and chemotherapy (47.10%). By the end of the follow-up period, 8, 003 (54.06%) TSCC patients had died, with a median survival time of 2.33 years. Cox proportional hazards regression analysis showed that the HR (95%CI) for TSCC-related deaths among patients not receiving surgery, radiotherapy and chemotherapy were 2.101 (1.972 to 2.239), 1.829 (1.702 to 1.966) and 1.023(0.951 to 1.100), respectively, compared to those who did receive these treatments; the HR (95%CI) for deaths due to other causes were 1.630 (1.513 to 1.756), 1.438 (1.318 to 1.570) and 1.328 (1.212 to 1.456), respectively. Compared to patients < 45 years old, the HR (95%CI) for TSCC-related deaths among patients ≥65 years old were 2.218 (1.933 to 2.545), and for deaths due to other causes were 6.178 (5.133 to 7.436).

    Conclusion 

    Radiotherapy, surgery and chemotherapy all contribute to improving the prognosis of TSCC patients. For elderly TSCC patients, particular attention should be paid to non-TSCC-related death risks.

  • [1]
    BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263. doi: 10.3322/caac.21834
    [2]
    SIEGEL R L, GIAQUINTO A N, JEMAL A. Cancer statistics, 2024[J]. CA Cancer J Clin, 2024, 74(1): 12-49. doi: 10.3322/caac.21820
    [3]
    郑荣寿, 陈茹, 韩冰峰, 等. 2022年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2024, 46(3): 221-231. doi: 10.3760/cma.j.cn112152-20240119-00035
    [4]
    CHOW L Q M. Head and neck cancer[J]. N Engl J Med, 2020, 382(1): 60-72. doi: 10.1056/NEJMra1715715
    [5]
    黄志刚, 文卫平, 毛薇, 等. 头颈肿瘤的综合治疗策略[J]. 临床耳鼻咽喉头颈外科杂志, 2023, 37(9): 673-690.
    [6]
    布洁, 高黎, 徐国镇, 等. 160例扁桃体癌的放射治疗及预后[J]. 中华放射肿瘤学杂志, 2001, 10(2): 104-107. doi: 10.3760/j.issn:1004-4221.2001
    [7]
    吴雪溪, 唐平章, 祁永发, 等. 108例扁桃体鳞癌治疗效果的回顾性分析[J]. 癌症, 2003, 22(10): 1070-1073.
    [8]
    王馨, 谢方云, 韩非, 等. 扁桃体癌治疗及预后因素分析[J]. 中华耳鼻咽喉头颈外科杂志, 2009, 44(10): 848-852. doi: 10.3760/cma.j.issn.1673-0860.2009.10.015
    [9]
    聂志强, 欧艳秋, 曲艳吉, 等. 临床生存数据新视角: 竞争风险模型[J]. 中华流行病学杂志, 2017, 38(8): 1127-1131. doi: 10.3760/cma.j.issn.0254-6450.2017.08.026
    [10]
    朱莹莹, 刁文雯, 祝小莉, 等. 晚期扁桃体鳞状细胞癌手术治疗与非手术治疗的疗效比较[J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(1): 42-47. doi: 10.3760/cma.j.cn115330-20210202-00053
    [11]
    CHE W Q, LI Y J, TSANG C K, et al. How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology[J]. Mil Med Res, 2023, 10(1): 50.
    [12]
    解松刚, 梁成通, 周丽娟, 等. 乳腺癌肺转移患者预后危险因素的分析及诺模图的构建[J]. 实用临床医药杂志, 2022, 26(18): 48-56. doi: 10.7619/jcmp.20220717
    [13]
    廖志晓, 邓跃扬, 朱津丽, 等. 早发性结直肠癌患者死亡竞争风险模型的构建[J]. 实用临床医药杂志, 2022, 26(22): 72-76. doi: 10.7619/jcmp.20222444
    [14]
    LI C Z, YANG J, ZHENG S, et al. Establishment and validation of a nomogram for tonsil squamous cell carcinoma: a retrospective study based on the SEER database[J]. Cancer Control, 2020, 27(1): 1073274820960481. doi: 10.1177/1073274820960481
    [15]
    陈绪清, 廖红明, 颜风波, 等. 基于SEER数据库的老年下咽癌患者预后预测模型建立与验证[J]. 国际耳鼻咽喉头颈外科杂志, 2023, 47(1): 13-18.
    [16]
    PARMAR A, MACLUSKEY M, GOLDRICK N M, et al. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy[J]. Cochrane Database Syst Rev, 2021, 12(12): CD006386.
    [17]
    中华口腔医学会口腔病理学专业委员会. 口腔癌及口咽癌病理诊断规范[J]. 中国口腔颌面外科杂志, 2020, 18(4): 289-296.
    [18]
    LECHNER M, LIU J, MASTERSON L, et al. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management[J]. Nat Rev Clin Oncol, 2022, 19(5): 306-327. doi: 10.1038/s41571-022-00603-7
    [19]
    LI Y B, JIANG B F, HUANG M D, et al. Retrospective study of the clinicopathological characteristics and prognosis of elderly patients with oropharyngeal squamous cell carcinoma[J]. J Int Med Res, 2021, 49(6): 3000605211016662. doi: 10.1177/03000605211016662
    [20]
    CHERAGHLOU S, YU P K, OTREMBA M D, et al. Treatment deintensification in human papillomavirus-positive oropharynx cancer: outcomes from the National Cancer Data Base[J]. Cancer, 2018, 124(4): 717-726. doi: 10.1002/cncr.31104
    [21]
    李卫芹, 杨雷, 王胜锋, 等. 生存数据的多状态竞争风险模型分析方法探索[J]. 中华预防医学杂志, 2021, 55(12): 1524-1529. doi: 10.3760/cma.j.cn112150-20211103-01019
    [22]
    朱志高, 梁凯. 口咽鳞状细胞癌患者预后影响因素分析[J]. 实用临床医药杂志, 2013, 17(11): 44-46, 49. doi: 10.7619/jcmp.201311014
  • Related Articles

    [1]ZHANG Wei, ZENG Yan, TANG Yujia. Effect of polyhexamethylene biguanide antibacterial dressing in skin ulcers around the stoma in patients with enterostomy undergoing radiotherapy and chemotherapy[J]. Journal of Clinical Medicine in Practice, 2024, 28(7): 129-132,137. DOI: 10.7619/jcmp.20233928
    [2]WANG Jie, YAN Xuebing, WEI Benfei. Effect observation of postoperative radiotherapy combined with systemic chemotherapy in treating patients with cervical cancer in early stage[J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 11-16. DOI: 10.7619/jcmp.20223685
    [3]PEI Bo, CHEN Jiaquan, DUAN Chunyan, YANG Mei, HE Du, CHEN Dian. Efficacy and safety of lobaplatin combined with radiotherapy versus cisplatin plus radiotherapy for locally advanced cervical cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(6): 106-109. DOI: 10.7619/jcmp.20201865
    [4]LI Honghong. Effect evaluation of radical surgery combined with radiotherapy and chemotherapy in treatment of patients with laryngeal carcinoma[J]. Journal of Clinical Medicine in Practice, 2019, 23(22): 37-39. DOI: 10.7619/jcmp.201922013
    [5]Research progress in radiotherapy and chemotherapy for early glottic laryngeal carcinoma[J]. Journal of Clinical Medicine in Practice, 2019, (3): 130-132. DOI: 10.7619/jcmp.201903037
    [6]HU Ruonan, GAO Qiong. Effect of comprehensive nursing intervention on radiotherapy and chemotherapy of advanced non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2017, (22): 32-34. DOI: 10.7619/jcmp.201722011
    [7]ZHAO Wenfang, XU Qin, WANG Fufang. Application of medical nursing of integrated management model in cervical cancer patients with postoperative radiotherapy and chemotherapy[J]. Journal of Clinical Medicine in Practice, 2016, (20): 102-105. DOI: 10.7619/jcmp.201620032
    [8]ZHANG Zhaoli, PI Yuanping, JI Jia, YUAN Wenxiu. Application of evaluation standard of health education for patients undergoing chemotherapy[J]. Journal of Clinical Medicine in Practice, 2016, (6): 50-52,56. DOI: 10.7619/jcmp.201606016
    [9]ZHAO Yihong, GAO Junmao, HE Heliang. Long-term efficacy of small target region intensity-modulated radiotherapy and chemotherapy in treatment of patients with nasopharyngeal cancer[J]. Journal of Clinical Medicine in Practice, 2015, (21): 73-76. DOI: 10.7619/jcmp.201521020
    [10]GU Ju-feng. 51 cases of patients with lung cancer during chemotherapy and radiotherapy nursing[J]. Journal of Clinical Medicine in Practice, 2011, (2): 5-6. DOI: 10.3969/j.issn.1672-2353.2011.02.003
  • Cited by

    Periodical cited type(10)

    1. 顾雅秋,沈丹. 人性化护理在外科手术室护理中的效果分析. 名医. 2023(14): 81-83 .
    2. 王静,孙静,王艳芳. 磁性医院管理理念在心血管外科手术室护理管理中的应用. 中华现代护理杂志. 2022(03): 387-391 .
    3. 王婷婷,冯文娟. 基于思维导图的无缝隙干预模式在泌尿外科手术室护理中的应用效果及对护理满意度的影响. 临床医学研究与实践. 2022(11): 177-180+184 .
    4. 曹江涛. 个性化护理服务在手术室患者中的应用. 保健医学研究与实践. 2021(S1): 202-204 .
    5. 张媛媛. 人性化护理模式在手术室护理中的应用价值评价. 中国继续医学教育. 2020(06): 181-183 .
    6. 王前前,胡亚平,张林波. 手术室整体护理对甲状腺手术患者的影响研究. 现代医药卫生. 2020(14): 2267-2269 .
    7. 冯雪玉. 手术室护理干预对结石性胆囊炎合并糖尿病患者的临床价值. 糖尿病新世界. 2020(19): 9-11 .
    8. 李瑾. 手术室人性化护理服务实施的应用效果分析. 山西医药杂志. 2020(24): 3519-3521 .
    9. 程宝玉. 舒适性护理应用于老年肺癌患者术中护理效果分析. 现代医学. 2019(12): 1544-1547 .
    10. 滕文久. 心理护理在手术室患者中的应用效果. 中国民康医学. 2019(23): 151-153 .

    Other cited types(0)

Catalog

    Article views (97) PDF downloads (12) Cited by(10)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return